An investigative report in Bloomberg concerning the FDA's 510(k) clearance process (previously vetted by the Institute of Medicine and reported on by the New York Times) took a close look at transvaginal mesh. The article revealed that many vaginal meshes were cleared for the market based solely on their s...
imilarity (known as "substantial equivalency") to other products of their kind. One of the earliest products was recalled by the manufacturer, yet other devices were cleared based on their equivalency to it. Furthermore, the initial, recalled product (Boston Scientific's ProteGen) was cleared based on its similarity to devices that were never designed as vaginal meshes to begin with. Using the Bloomberg article as a starting point and incoporating original research from the FDA's database, ClassAction.org traced this process and adapted the results into this infographic.
Never miss a thing with our weekly newsletter. We'll send you the latest and greatest infographics, news and all things Visually.
Go ahead, you can always opt out anytime with just one click.
Copy the code below
Newsletters are boring. So we made ours visual. Subscribe now.
Thank you for subscribing. We sent an email, please click the link to complete
Tell your story visually before December 31st and get a free iPad Air!*
The holidays are a great time to tell your brand story. From Black Friday trends and Mobile Shopping guides to the Best and Worst Times to Book Travel and Thanksgiving etiquette, the Visually team will help you craft your brand's unique stories and raise your social profile during the noisy holiday season.